India · Delayed Price · Currency is INR Intra-Cellular Therapies Statistics
Total Valuation
BOM:544009 has a market cap or net worth of INR 139.66 billion. The enterprise value is 136.79 billion.
| Market Cap | 139.66B |
| Enterprise Value | 136.79B |
Important Dates
The last earnings date was Tuesday, July 29, 2025.
| Earnings Date | Jul 29, 2025 |
| Ex-Dividend Date | Sep 17, 2024 |
Share Statistics
| Current Share Class | 173.47M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.09% |
| Shares Change (QoQ) | -0.03% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 22.46M |
Valuation Ratios
The trailing PE ratio is 38.95 and the forward PE ratio is 34.58.
| PE Ratio | 38.95 |
| Forward PE | 34.58 |
| PS Ratio | 11.43 |
| PB Ratio | 12.33 |
| P/TBV Ratio | 12.33 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 38.15 |
| EV / Sales | 11.20 |
| EV / EBITDA | 27.56 |
| EV / EBIT | 28.46 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.04 |
| Debt / FCF | n/a |
| Interest Coverage | 631.68 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 30.05% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 27.33M |
| Profits Per Employee | 8.02M |
| Employee Count | 447 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BOM:544009 has paid 1.21 billion in taxes.
| Income Tax | 1.21B |
| Effective Tax Rate | 25.21% |
Stock Price Statistics
The stock price has increased by +60.10% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +60.10% |
| 50-Day Moving Average | 878.85 |
| 200-Day Moving Average | 725.59 |
| Relative Strength Index (RSI) | 43.00 |
| Average Volume (20 Days) | 89,939 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:544009 had revenue of INR 12.22 billion and earned 3.59 billion in profits. Earnings per share was 20.67.
| Revenue | 12.22B |
| Gross Profit | 6.52B |
| Operating Income | 4.81B |
| Pretax Income | 4.79B |
| Net Income | 3.59B |
| EBITDA | 4.96B |
| EBIT | 4.81B |
| Earnings Per Share (EPS) | 20.67 |
Balance Sheet
The company has 3.06 billion in cash and 199.86 million in debt, giving a net cash position of 2.86 billion.
| Cash & Cash Equivalents | 3.06B |
| Total Debt | 199.86M |
| Net Cash | 2.86B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 11.33B |
| Book Value Per Share | 65.35 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 53.32%, with operating and profit margins of 39.34% and 29.35%.
| Gross Margin | 53.32% |
| Operating Margin | 39.34% |
| Pretax Margin | 39.24% |
| Profit Margin | 29.35% |
| EBITDA Margin | 40.62% |
| EBIT Margin | 39.34% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 1.00, which amounts to a dividend yield of 0.12%.
| Dividend Per Share | 1.00 |
| Dividend Yield | 0.12% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | -0.09% |
| Shareholder Yield | 0.03% |
| Earnings Yield | 2.57% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |